Title: Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis
and cirrhosis in COVID-19 patients with concurrent liver diseases
Version: 1 Date: 01 Mar 2025
Reviewer's report:
The manuscript has been revised according to my suggestions and appears improved. I consider
it acceptable for publication
Title: Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis
and cirrhosis in COVID-19 patients with concurrent liver diseases
Version: 1 Date: 01 Mar 2025
Reviewer's report:
The manuscript has been revised according to my suggestions and appears improved. I consider
it acceptable for publication
Please review this paper.
user
Title: Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis
and cirrhosis in COVID-19 patients with concurrent liver diseases
Version: 1 Date: 01 Mar 2025
Reviewer's report:
The manuscript has been revised according to my suggestions and appears improved. I consider
it acceptable for publication
assistant